Oxyfedrine

Oxyfedrine

Clinical data
ATC code	C01DX03 (WHO)
Identifiers
IUPAC name 3-[(1-Hydroxy-1-phenylpropan-2-yl)amino]-1-(3-methoxyphenyl)propan-1-one
PubChem CID	27454
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H23NO3
Molar mass	313.39 g/mol

WikiDoc Resources for Oxyfedrine
Articles
Most recent articles on Oxyfedrine Most cited articles on Oxyfedrine Review articles on Oxyfedrine Articles on Oxyfedrine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Oxyfedrine Images of Oxyfedrine Photos of Oxyfedrine Podcasts & MP3s on Oxyfedrine Videos on Oxyfedrine
Evidence Based Medicine
Cochrane Collaboration on Oxyfedrine Bandolier on Oxyfedrine TRIP on Oxyfedrine
Clinical Trials
Ongoing Trials on Oxyfedrine at Clinical Trials.gov Trial results on Oxyfedrine Clinical Trials on Oxyfedrine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Oxyfedrine NICE Guidance on Oxyfedrine NHS PRODIGY Guidance FDA on Oxyfedrine CDC on Oxyfedrine
Books
Books on Oxyfedrine
News
Oxyfedrine in the news Be alerted to news on Oxyfedrine News trends on Oxyfedrine
Commentary
Blogs on Oxyfedrine
Definitions
Definitions of Oxyfedrine
Patient Resources / Community
Patient resources on Oxyfedrine Discussion groups on Oxyfedrine Patient Handouts on Oxyfedrine Directions to Hospitals Treating Oxyfedrine Risk calculators and risk factors for Oxyfedrine
Healthcare Provider Resources
Symptoms of Oxyfedrine Causes & Risk Factors for Oxyfedrine Diagnostic studies for Oxyfedrine Treatment of Oxyfedrine
Continuing Medical Education (CME)
CME Programs on Oxyfedrine
International
Oxyfedrine en Espanol Oxyfedrine en Francais
Business
Oxyfedrine in the Marketplace Patents on Oxyfedrine
Experimental / Informatics
List of terms related to Oxyfedrine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oxyfedrine is a vasodilator. Oxyfedrine was found to depress the tonicity of coronary vessels, improve myocardial metabolism (so that heart can sustain hypoxia better) and also exert a positive chronotropic and inotrophic effects, thereby not precipitating angina pectoris. The latter property (positive chronotropic and inotrophic effects) is particularly important, because other vasodilators used in angina may be counter productive causing coronary steal phenomenon.

Synergestic effects with antibiotics have been suggested.